Xu H - Search Results

1

[A weak D type 59 case identified in the Chinese Han population].

Liao Z, Xu H, Liu C, Wang R, Xiang K, Feng J, Le F, Wu T, Tao Z. Liao Z, et al. Among authors: xu h. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):261-264. doi: 10.3760/cma.j.issn.1003-9406.2018.02.026. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018. PMID: 29653006 Chinese.

2

[Identification of Phenotype and Genotype in One Case with Weak D blood group].

Xu HY, Wang R, Lin CY, Yu SF, Liu CH, Tao ZH, Liao ZP. Xu HY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1800-1803. doi: 10.7534/j.issn.1009-2137.2018.06.036. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 30501723 Chinese.

3

[Identification of A Case of DEL Blood Group with DAT Positive Phenotype and Pedigree Analysis].

Xiang KH, Xu HY, Liu CH, Wang R, Yu SF, Yu P, Xu LF, Tao ZH, Yu LF. Xiang KH, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Oct;27(5):1649-1653. doi: 10.19746/j.cnki.issn.1009-2137.2019.05.045. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 31607327 Chinese.

4

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.

Gong X, Zhang Y, He X, Moloudizargari M, Yu T, Wang L, Liu W, Jin L, Xu H, Xu Y, Tao Z, Qian W. Gong X, et al. Among authors: xu h, xu y. Exp Hematol Oncol. 2023 Jun 30;12(1):57. doi: 10.1186/s40164-023-00424-z. Exp Hematol Oncol. 2023. PMID: 37391809 Free PMC article.

5

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.

Gong X, He X, Wang L, Yu T, Liu W, Xu H, Jin L, Li X, Zhang B, Tao Z, Qian W. Gong X, et al. Among authors: xu h. Exp Hematol Oncol. 2024 Feb 16;13(1):17. doi: 10.1186/s40164-024-00486-7. Exp Hematol Oncol. 2024. PMID: 38365742 Free PMC article.

6

[Development of an intelligent control system for radiography].

Li JP, Li XL, Ma LY, Xin XL, You SB, Han LH, Li ZY, Xu HY. Li JP, et al. Zhongguo Yi Liao Qi Xie Za Zhi. 2005 May;29(3):182-3. Zhongguo Yi Liao Qi Xie Za Zhi. 2005. PMID: 16124624 Chinese.

7

The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy.

Liu S, Kang M, Ren Y, Zhang Y, Ba Y, Deng J, Luo P, Cheng Q, Xu H, Weng S, Zuo A, Han X, Liu Z, Pan T, Gao L. Liu S, et al. Among authors: xu h. Cell Prolif. 2025 Jan 26:e13814. doi: 10.1111/cpr.13814. Online ahead of print. Cell Prolif. 2025. PMID: 39865437 Review.

8

Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling.

Shao W, Xu H, Zeng K, Ye M, Pei R, Wang K. Shao W, et al. Among authors: xu h. Stem Cell Res Ther. 2025 Jan 26;16(1):27. doi: 10.1186/s13287-025-04139-2. Stem Cell Res Ther. 2025. PMID: 39865320 Review.

9

A cross-sectional study on the association between physical activity and the risk of colon cancer based on NHANES 2007-2018.

Zou D, Xin X, Xu Y, Xu H, Xu T. Zou D, et al. Among authors: xu h. Sci Rep. 2025 Jan 26;15(1):3297. doi: 10.1038/s41598-025-88067-4. Sci Rep. 2025. PMID: 39865142

10

Efficient Discovery of Robust Prognostic Biomarkers and Signatures in Solid Tumors.

Liu Z, Deng J, Xu H, Liu L, Zhang Y, Ba Y, Zhang Z, He F, Xie L. Liu Z, et al. Among authors: xu h. Cancer Lett. 2025 Jan 24:217502. doi: 10.1016/j.canlet.2025.217502. Online ahead of print. Cancer Lett. 2025. PMID: 39864538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,896 results

Search Page

Filters